EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration

Hector Albert-Gasco iD, Heather L Smith, Beatriz Alvarez-Castelao, Dean Swinden, Mark Halliday, Sudha Janaki-Raman, Adrian J Butcher, Giovanna R Mallucci iD

Brain · 01.02.2024 · 147 (2) · 649-664

DOI: 10.1093/brain/awad313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 13.09.2023. Verfasst von Hector Albert-Gasco und 7 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, UK. Hauptthemen laut MEDLINE: Prions, Trazodone, Prion Diseases, Neurodegenerative Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK, Cambridge Centre for Parkinson's Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The unfolded protein response (UPR) is rapidly gaining momentum as a therapeutic target for protein misfolding neurodegenerative diseases, in which its overactivation results in sustained translational repression leading to synapse loss and neurodegeneration. In mouse models of these disorders, from Alzheimer’s to prion disease, modulation of the pathway—including by the licensed drug, trazodone—restores global protein synthesis rates with profound neuroprotective effects. However, the precise nature of the translational impairment, in particular the specific proteins affected in disease, and their response to therapeutic UPR modulation are poorly understood. We used non-canonical amino acid tagging (NCAT) to measure de novo protein synthesis in the brains of prion-diseased mice with and without trazodone treatment, in both whole hippocampus and cell-specifically. During disease the predominant nascent proteome changes occur in synaptic, cytoskeletal and mitochondrial proteins in both hippocampal neurons and astrocytes. Remarkably, trazodone treatment for just 2 weeks largely restored the whole disease nascent proteome in the hippocampus to that of healthy, uninfected mice, predominantly with recovery of proteins involved in synaptic and mitochondrial function. In parallel, trazodone treatment restored the disease-associated decline in synapses and mitochondria and their function to wild-type levels. In conclusion, this study increases our understanding of how translational repression contributes to neurodegeneration through synaptic and mitochondrial toxicity via depletion of key proteins essential for their function. Further, it provides new insights into the neuroprotective mechanisms of trazodone through reversal of this toxicity, relevant for the treatment of neurodegenerative diseases via translational modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrionsTrazodonePrion DiseasesNeurodegenerative DiseasesAlzheimer DiseaseMiceAnimalsProteomeSynapses

Stichwörter der Autor:innen

UPR/ISRmitochondrianascent proteomeneurodegenerationsynapsestranslational repressiontrazodone

Substanzen

PrionsProteomeTrazodone

Autor:innen und Institutionen

  • UK Dementia Research Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, UK.
  • Cambridge Institute of Science, Altos Labs, Great Abington CB21 6GP, UK.
  • Department of Biochemistry and Molecular Biology, Veterinary School, Complutense University of Madrid, 28040 Madrid, Spain.
  • The San Carlos Hospital Health Research Institute, IdISSC, 28040 Madrid, Spain.
  • Altos Labs Inc, Redwood City, CA 94065, USA.

ORCID-Profile: Hector Albert-Gasco, Giovanna R Mallucci

Förderung

  • UK Medical Research Council
  • Alzheimer's Society and Alzheimer's Research UK
  • Cambridge Centre for Parkinson's Plus
  • EU Joint Programme Neurodegenerative Disease Research
  • Spanish Ministry of Science and innovation
  • Autonomous Community of Madrid
  • Alzheimer’s Society and Alzheimer’s Research UK
  • Cambridge Centre for Parkinson’s Plus

Zitieren

APA

Albert-Gasco, H., Smith, H. L., Alvarez-Castelao, B., Swinden, D., Halliday, M., Janaki-Raman, S., Butcher, A. J., & Mallucci, G. R. (2024). Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration. Brain, 147(2), 649-664. https://doi.org/10.1093/brain/awad313

Vancouver

Albert-Gasco H, Smith HL, Alvarez-Castelao B, Swinden D, Halliday M, Janaki-Raman S, et al. Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration. Brain. 2024;147(2):649-664. doi:10.1093/brain/awad313

BibTeX
@article{AlbertGasco2024,
  author = {Albert-Gasco, Hector and Smith, Heather L and Alvarez-Castelao, Beatriz and Swinden, Dean and Halliday, Mark and Janaki-Raman, Sudha and Butcher, Adrian J and Mallucci, Giovanna R},
  title = {Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {2},
  pages = {649--664},
  doi = {10.1093/brain/awad313}
}
Kostenlos starten →